학술논문
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Document Type
Article
Author
Tella, Sri Harsha; Foster, Nathan; Qian, Shi; Nguyen, Tran; Borad, Mitesh J; McWilliams, Robert R; Alberts, Steven R; Ma, Wen Wee; Chakrabarti, Sakti; Fruth, Briant; Wessling, Jaclynn; Hartgers, Mindy; Washburn, Leslie; Fernandez-Zapico, Martin E; Hogenson, Tara L; Pitot, Henry; Jin, Zhaohui; Mahipal, Amit
Source
Oncologist; Oct2023, Vol. 28 Issue 10, p917-917, 1p, 4 Charts, 3 Graphs
Subject
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)